Susquehanna Maintains Neutral on Genpact, Raises Price Target to $37

Benzinga Newsdesk www.benzinga.com Positive 54.0%

Neg 0% Neu 0% Pos 54%

Susquehanna analyst James Friedman maintains Genpact (NYSE:G) with a Neutral and raises the price target from $33 to $37.